THE Food and Drug Administration (FDA) has given its emergency use authorization (EUA) approval to the coronavirus disease 2019 (Covid-19) vaccine made by British-Swedish drugmaker AstraZeneca.
During the Laging Handa media briefing on Thursday, FDA Director-General Rolando Enrique Domingo said that the interim data for AZD1222 from its ongoing phase three trials had an efficacy of 70 percent.
Already have an active account? Log in here.
Continue reading with one of these options:
Continue reading with one of these options:
Premium + Digital Edition
Ad-free access
P 80 per month
(billed annually at P 960)
- Unlimited ad-free access to website articles
- Limited offer: Subscribe today and get digital edition access for free (accessible with up to 3 devices)
TRY FREE FOR 14 DAYS
See details
See details
If you have an active account, log in
here
.